{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:34:15Z","timestamp":1778916855861,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.iac.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:06:46Z","timestamp":1573060006000},"page":"97-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Peanut Oral Immunotherapy"],"prefix":"10.1016","volume":"40","author":[{"given":"Mimi L.K.","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana C.","family":"Lozinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paxton","family":"Loke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iac.2019.09.005_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2016.01.001","article-title":"Food allergen immunotherapy: current status and prospects for the future","volume":"137","author":"Wood","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2017.11.004","article-title":"Treatment for food allergy","volume":"141","author":"Burks","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.iac.2017.09.008","article-title":"Adjuvant therapies in food immunotherapy","volume":"38","author":"Loh","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","article-title":"Clinical efficacy and immune regulation with peanut oral immunotherapy","volume":"124","author":"Jones","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A\u00a0randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","article-title":"Oral peanut immunotherapy in children with peanut anaphylaxis","volume":"126","author":"Blumchen","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2019.09.005_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2222.2011.03699.x","article-title":"Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome","volume":"41","author":"Anagnostou","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"9925","key":"10.1016\/j.iac.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","article-title":"Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)","volume":"133","author":"Syed","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"A\u00a0randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy","volume":"135","author":"Narisety","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.005_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/apa.13668","article-title":"Double-blind placebo-controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation","volume":"106","author":"Kukkonen","year":"2017","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/pai.13066","article-title":"Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial","volume":"30","author":"Reier-Nilsen","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"21","key":"10.1016\/j.iac.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaip.2018.05.023","article-title":"Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/all.13124","article-title":"Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"72","author":"Nurmatov","year":"2017","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaci.2013.12.1040","article-title":"State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous","volume":"133","author":"Jones","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/pai.12100","article-title":"Oral immunotherapy and tolerance induction in childhood","volume":"24","author":"Tang","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1016\/j.iac.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaci.2007.11.024","article-title":"Early clinical predictors of remission of peanut allergy in children","volume":"121","author":"Ho","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2019.09.005_bib23","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jaci.2015.01.002","article-title":"Natural history of peanut allergy and predictors of resolution in the first 4 years of life: a population-based assessment","volume":"135","author":"Peters","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2019.09.005_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2016.07.030","article-title":"Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy","volume":"139","author":"Virkud","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"AB256","DOI":"10.1016\/j.jaci.2018.12.781","article-title":"Longer-term safety and efficacy measures of AR101 oral immunotherapy for peanut allergy: results from a phase 3 follow-on study","volume":"143","author":"Carr","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10187","key":"10.1016\/j.iac.2019.09.005_bib26","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.iac.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaip.2016.11.020","article-title":"The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy","volume":"5","author":"Hill","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2019.09.005_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.anai.2017.11.016","article-title":"Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy","volume":"120","author":"Petroni","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3389\/fimmu.2018.02624","article-title":"Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy","volume":"9","author":"Wright","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.iac.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2013.05.006","article-title":"Long-term follow-up of oral immunotherapy for cow's milk allergy","volume":"132","author":"Keet","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.aller.2011.05.004","article-title":"Adverse effects during specific oral tolerance induction: in home phase","volume":"40","author":"Barbi","year":"2012","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib33","doi-asserted-by":"crossref","first-page":"AB247","DOI":"10.1016\/j.jaci.2018.12.755","article-title":"Long term follow-up of oral and sublingual immunotherapy for peanut allergy","volume":"143","author":"Dantzer","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.005_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s40124-016-0116-1","article-title":"Novel treatments for established food allergies","volume":"4","author":"Hsiao","year":"2016","journal-title":"Curr Pediatr Rep"},{"issue":"3","key":"10.1016\/j.iac.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2352-4642(17)30041-X","article-title":"Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hsiao","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12016-018-8694-z","article-title":"Enhancing the safety and efficacy of food allergy immunotherapy: a review of adjunctive therapies","volume":"55","author":"Virkud","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.iac.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/all.13211","article-title":"Changes in patient quality of life during oral immunotherapy for food allergy","volume":"72","author":"Rigbi","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2019.09.005_bib39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.5415\/apallergy.2019.9.e1","article-title":"Efficacy and safety of oral immunotherapy for peanut allergy: a pilot study in Singaporean children","volume":"9","author":"Zhong","year":"2018","journal-title":"Asia Pac Allergy"},{"issue":"5","key":"10.1016\/j.iac.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.anai.2012.08.015","article-title":"Effect of oral immunotherapy to peanut on\u00a0food-specific quality of life","volume":"109","author":"Factor","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"AB29","DOI":"10.1016\/j.jaci.2011.12.770","article-title":"Participation in peanut oral immunotherapy improves quality of life","volume":"129","author":"Kamilaris","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/all.13330","article-title":"The longitudinal impact of probiotic and peanut oral immunotherapy on health-related quality of life","volume":"73","author":"Dunn Galvin","year":"2018","journal-title":"Allergy"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:43:46Z","timestamp":1760179426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856119300670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0889856119300670"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.005","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peanut Oral Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}